Essential thrombocytosis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Epidemiology== | ==Epidemiology== | ||
Essential thrombocytosis is diagnosed at a rate of about 2 to 3 per 100,000 individuals annually.<ref>{{cite journal | author = Mesa R, Silverstein M, Jacobsen S, Wollan P, Tefferi A | title = Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. | journal = Am J Hematol | volume = 61 | issue = 1 | pages = 10-5 | year = 1999 | id = PMID 10331505}}</ref><ref>{{cite journal | author = Kutti J, Ridell B | title = Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis. | journal = Pathol Biol (Paris) | volume = 49 | issue = 2 | pages = 164-6 | year = 2001 | id = PMID 11317963}}</ref> | Essential thrombocytosis is diagnosed at a rate of about 2 to 3 per 100,000 individuals annually.<ref>{{cite journal | author = Mesa R, Silverstein M, Jacobsen S, Wollan P, Tefferi A | title = Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. | journal = Am J Hematol | volume = 61 | issue = 1 | pages = 10-5 | year = 1999 | id = PMID 10331505}}</ref><ref>{{cite journal | author = Kutti J, Ridell B | title = Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis. | journal = Pathol Biol (Paris) | volume = 49 | issue = 2 | pages = 164-6 | year = 2001 | id = PMID 11317963}}</ref> ET is a rare idiopathic condition affecting about 24 for every million people in the world<ref>Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015</ref>.Although ET can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.<ref>Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.</ref> | ||
==References== | ==References== | ||
Revision as of 14:20, 29 October 2015
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis epidemiology and demographics |
|
FDA on Essential thrombocytosis epidemiology and demographics |
|
CDC on Essential thrombocytosis epidemiology and demographics |
|
Essential thrombocytosis epidemiology and demographics in the news |
|
Blogs on Essential thrombocytosis epidemiology and demographics |
|
Risk calculators and risk factors for Essential thrombocytosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology
Essential thrombocytosis is diagnosed at a rate of about 2 to 3 per 100,000 individuals annually.[1][2] ET is a rare idiopathic condition affecting about 24 for every million people in the world[3].Although ET can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.[4]
References
- ↑ Mesa R, Silverstein M, Jacobsen S, Wollan P, Tefferi A (1999). "Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995". Am J Hematol. 61 (1): 10–5. PMID 10331505.
- ↑ Kutti J, Ridell B (2001). "Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis". Pathol Biol (Paris). 49 (2): 164–6. PMID 11317963.
- ↑ Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015
- ↑ Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.